Please Wait

Applying Filters...

Cefotaxime
KDMF
Table View

Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

Data Compilation
#PharmaFlow

Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

Stock Recap
#PipelineProspector

Cefotaxime

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 14 USDMF, 17 CEP/COS, 1 JDMF, 5 EU WC, 7 KDMF, 1 NDC API, 23 Listed Suppliers, $ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

261 FDF Dossiers, 40 FDA Orange Book, 104 Europe, 2 Canada, 27 South Africa, 88 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 6 News #PharmaBuzz

GLOBAL SALES INFORMATION

54 Regulatory FDF Prices

54 Regulatory FDF Prices

MARKET PLACE

22 APIs, 10 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 4 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
27/09/2025	Hanmi Pharmaceutical	South Korea	Hanmi Fine Chemical Co., Ltd.	20090924-118-G-23-02	Cefotaxime sodium	2009-09-24	Hanmi Fine Chemical Co., Ltd.	South Korea	57 Gyeongje-ro, Siheung-si, Gyeonggi-do
27/09/2025	Korea Fine Chemical	South Korea	Hawon Precision Chemical Co., Ltd.	20100831-118-G-98-05	Cefotaxime sodium	2010-08-31	Hawon Precision Chemical Co., Ltd.	South Korea	404-18 Nojang-ri, Jeondong-myeon, Yeongi-gun, Chungcheongnam-do

Contact us
to update this info

Cefotaxime

Cefotaxime

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers

14 USDMF

17 CEP/COS

1 JDMF

5 EU WC

7 KDMF

1 NDC API

23 Listed Suppliers

$ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

261 FDF Dossiers

40 FDA Orange Book

104 Europe

2 Canada

27 South Africa

88 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

DIGITAL CONTENT

1 Data Compilation #PharmaFlow

6 News #PharmaBuzz

GLOBAL SALES INFORMATION

54 Regulatory FDF Prices

MARKET PLACE

22 APIs

10 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM

4 Others

Filters

INJECTABLE;INJECTION - EQ 10GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons